Investment & Strategy Bootcamp: Tuesday, September 17

Gain insights into the decision-making process of VCs, investors and big pharma search and evaluation teams to support your partnering and funding strategy, while reflecting on market access and profitability to guarantee commercial success when the time comes.

Full Investment & Strategy Bootcamp Agenda:

8:00 am Check In Open & Coffee Networking

Assessing the Current & Future Funding Environment for Cell Therapies

9:00 am Landscape Review of Deals & Investment in Cell Therapy: Beacon Targeted Therapies

Synopsis

  • A Review of the Cell Therapy Investment Landscape 
  • A discussion on past and present cell therapy funding, partnership and collaboration trends 
  • An evaluation of cell therapies for autoimmune diseases and its observed investor interest 

9:30 am Investors Panel: What’s the Next Big Thing?

Synopsis

  • Identifying gaps and opportunities within the competitive cell therapy space 
  • Clarifying expectations in data required to ensure robust investment

10:30 am Morning Break & Speed Networking

Reaffirming Internal Strategy to Promote Corporate Success

11:30 am The Team Sport of Advancing Cell Therapies

  • Efe Egharevba Executive Director, Product Team Leader, Kite Pharma

Synopsis

  • The importance of cross functional, stage appropriate teams and nuances of cell therapy development
  • Bringing teams together: who, what, when, where and why?
  • The importance of ensuring checks and balances

12:00 pm Streamlining Pricing & Reimbursement to Facilitate Market Access

Synopsis

  • Outlining value based and comparative pricing models to navigate optimal pricing
  • Understanding market access options to maximize profitability 
  • Demonstrating long-term value of therapies to provide evidence for pricing and reimbursement

12:30 pm Lunch Break & Networking

Survival of the Fittest: Securing Cash Runways to Support Progression

1:30 pm Pharma Panel: Obtaining Winning Industry Partnerships to Advance Cell Therapies

  • Arun Pores Fernando Director - Business Development, Search and Evaluation, Cell Therapy, Bristol Myers Squibb
  • Gadi Bornstein Senior Director - External Innovation, Discovery, Product Development & Supply, Johnson & Johnson Innovative Medicine
  • Natalia Ulyanova Director - Business Development & Oncology, Astellas Pharma
  • Alexandria Cogdill Executive Director & Head of Global Research & Technology S&E, External Innovation, Global Business Development, Daiichi Sankyo

Synopsis

  • Identifying promising merger, acquisition, and collaboration opportunities
  • Building strong relationships to promote robust product development 

2:30 pm Afternoon Break & Networking

3:00 pm Round Table:How to Position & Distinguish your Technology’s Platform Capabilities to Address Challenges when Searching for Investment in a Competitive Environment

Synopsis

  • Understanding of key trends and how your approach could match investors interest
  • Clear positioning of your technology and differentiating factors that lead to well-defined market opportunity and higher probability of success
  • Continuous education and information (investors and community) on how to increase the chance of clearing key milestones towards approval for patient use
  • Proper insight sharing with key stakeholders and focus on key learnings from peers’ successes and failures

3:30 pm CAR-TCR Shark Tank

Synopsis

Now it’s your turn. Make the most of this opportunity to put your learnings into action by staging a practice pitch to an experienced panel to gain feedback. Set your company up for success for when the inevitable time comes to bid for financing and partnership.

4:00 pm End of Bootcamp Day & Start of Diversity Evening

NEXT PAGE: POST-CONFERENCE FOCUS DAYS
FULL AGENDA
REGISTER
PARTNER